Market Tracker

11/24 12:52pm ET

Nektar Therapeutics (NASDAQ:NKTR)

15.10
Real-Time Quote
 +0.43 / +2.93%
Today’s Change
10.10
Today|||52-Week Range
15.48
+33.04%
Year-to-Date

Today’s Trading

Previous close14.67
Today’s open14.72
Day’s range14.70 - 15.48
Volume1,338,942
Average volume (3 months)1,274,897
Market cap$1.9B
Dividend yield--
Data as of 12:37pm ET, 11/24/2014

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+68.65%
Earnings growth (next 5 years)+53.58%
Revenue growth (last year)+83.42%
P/E ratioNM
Price/Sales8.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DYAXDyax Corp+0.41+3.09%
ABCOAdvisory Board Co+1.18+2.86%
KERXKeryx Biopharmaceuti...+0.29+1.88%
INCRINC Research Holding...+0.61+2.59%
Data as of 12:52pm ET, 11/24/2014

Financials

Next reporting dateFebruary 25, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$148.9M
Annual profit (last year)-$162.0M
Net profit margin-108.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts